雌二醇在脓毒症及相关器官功能障碍的 最新研究进展
Latest Research Advances on Estradiol in Sepsis and Sepsis-Related Organ Dysfunction
DOI: 10.12677/acm.2026.1641759, PDF,   
作者: 谷立宏, 张 云:吉首大学医学院,湖南 吉首;株洲市中心医院泌尿外一科,湖南 株洲;李钰琦, 田 章, 舒林飞, 谌 磊*:株洲市中心医院泌尿外一科,湖南 株洲
关键词: 雌二醇脓毒症器官功能障碍炎症反应氧化应激免疫调节Estradiol Sepsis Organ Dysfunction Inflammatory Response Oxidative Stress Immunomodulation
摘要: 脓毒症是宿主对感染的反应失调所致的危及生命的器官功能障碍,全球发病率和死亡率居高不下。流行病学数据显示脓毒症预后存在显著性别差异,绝经前女性发病率和死亡率低于同龄男性,提示雌激素可能发挥保护作用。雌二醇(E2)作为生物活性最强的雌激素,具有抗炎、抗氧化、保护内皮等多重效应。本文系统综述雌二醇在脓毒症及其相关器官功能障碍(急性肾损伤、心肌病、肝损伤、肺损伤等)中的研究进展,梳理其与疾病预后的临床相关性,阐明其调控炎症、氧化应激和细胞凋亡的分子机制,并分析当前研究的矛盾与争议,探讨其作为脓毒症辅助治疗的临床转化前景与挑战。
Abstract: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, with persistently high global incidence and mortality. Epidemiological data show significant sex-based differences in sepsis outcomes: premenopausal women have lower incidence and mortality than age-matched men, suggesting a potential protective role of estrogen. Estradiol (E2), the most biologically active estrogen, exerts multiple effects including anti-inflammatory, antioxidant, and endothelial-protective actions. This article systematically reviews research progress on estradiol in sepsis and related organ dysfunction (acute kidney injury, septic cardiomyopathy, liver injury, lung injury, etc.), summarizes its clinical associations with prognosis, elucidates molecular mechanisms by which it regulates inflammation, oxidative stress, and apoptosis, and analyzes current inconsistencies and controversies. Finally, it discusses the translational prospects and challenges of estradiol as an adjunctive therapy for sepsis.
文章引用:谷立宏, 李钰琦, 田章, 张云, 舒林飞, 谌磊. 雌二醇在脓毒症及相关器官功能障碍的 最新研究进展[J]. 临床医学进展, 2026, 16(4): 4856-4865. https://doi.org/10.12677/acm.2026.1641759

参考文献

[1] Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211. [Google Scholar] [CrossRef] [PubMed]
[2] GBD 2021 Sepsis Collaborators (2025) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2021: A Systematic Analysis. Lancet Glob Health, 13, e1431-e1440.
[3] Poston, J.T. and Koyner, J.L. (2019) Sepsis Associated Acute Kidney Injury. BMJ, 364, k4891. [Google Scholar] [CrossRef] [PubMed]
[4] Angele, M.K., Pratschke, S., Hubbard, W.J. and Chaudry, I.H. (2013) Gender Differences in Sepsis: Cardiovascular and Immunological Aspects. Virulence, 5, 12-19. [Google Scholar] [CrossRef] [PubMed]
[5] Fuentes, N. and Silveyra, P. (2019) Estrogen Receptor Signaling Mechanisms. Advances in Protein Chemistry and Structural Biology, 116, 135-170.
[6] Chaudry, I.H., Samy, T.S.A., Schwacha, M.G., Wang, P., Rue, L.W. and Bland, K.I. (2003) Endocrine Targets in Experimental Shock. Journal of Trauma: Injury, Infection & Critical Care, 54, S118-S125. [Google Scholar] [CrossRef] [PubMed]
[7] Lichtenstern, C., Brenner, T., Bardenheuer, H.J. and Weigand, M.A. (2012) Predictors of Survival in Sepsis: What Is the Best Inflammatory Marker to Measure? Current Opinion in Infectious Diseases, 25, 328-336. [Google Scholar] [CrossRef] [PubMed]
[8] Tsang, G., Insel, M.B., Weis, J.M., Morgan, M.A.M., Gough, M.S., Frasier, L.M., et al. (2016) Bioavailable Estradiol Concentrations Are Elevated and Predict Mortality in Septic Patients: A Prospective Cohort Study. Critical Care, 20, Article No. 335. [Google Scholar] [CrossRef] [PubMed]
[9] Gruber, C.J., Tschugguel, W., Schneeberger, C. and Huber, J.C. (2002) Production and Actions of Estrogens. New England Journal of Medicine, 346, 340-352. [Google Scholar] [CrossRef] [PubMed]
[10] Prossnitz, E.R. and Barton, M. (2011) The G-Protein-Coupled Estrogen Receptor GPER in Health and Disease. Nature Reviews Endocrinology, 7, 715-726. [Google Scholar] [CrossRef] [PubMed]
[11] Levin, E.R. (2005) Integration of the Extranuclear and Nuclear Actions of Estrogen. Molecular Endocrinology, 19, 1951-1959. [Google Scholar] [CrossRef] [PubMed]
[12] Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., et al. (2007) Estrogen Receptors: How Do They Signal and What Are Their Targets. Physiological Reviews, 87, 905-931. [Google Scholar] [CrossRef] [PubMed]
[13] Chakraborty, B., Byemerwa, J., Krebs, T., Lim, F., Chang, C. and McDonnell, D.P. (2022) Estrogen Receptor Signaling in the Immune System. Endocrine Reviews, 44, 117-141. [Google Scholar] [CrossRef] [PubMed]
[14] Sun, Z., Pan, Y., Qu, J., Xu, Y., Dou, H. and Hou, Y. (2020) 17β-Estradiol Promotes Trained Immunity in Females against Sepsis via Regulating Nucleus Translocation of Relb. Frontiers in Immunology, 11, Article ID: 1591. [Google Scholar] [CrossRef] [PubMed]
[15] Straub, R.H. (2007) The Complex Role of Estrogens in Inflammation. Endocrine Reviews, 28, 521-574. [Google Scholar] [CrossRef] [PubMed]
[16] Kovats, S. (2015) Estrogen Receptors Regulate Innate Immune Cells and Signaling Pathways. Cellular Immunology, 294, 63-69. [Google Scholar] [CrossRef] [PubMed]
[17] Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[18] Seymour, C.W., Liu, V.X., Iwashyna, T.J., Brunkhorst, F.M., Rea, T.D., Scherag, A., et al. (2016) Assessment of Clinical Criteria for Sepsis: For the Third International Con-Sensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 762-774. [Google Scholar] [CrossRef] [PubMed]
[19] La Via, L., Sangiorgio, G., Stefani, S., Marino, A., Nunnari, G., Cocuzza, S., et al. (2024) The Global Burden of Sepsis and Septic Shock. Epidemiologia, 5, 456-478. [Google Scholar] [CrossRef] [PubMed]
[20] Liu, S.F. and Malik, A.B. (2006) Nf-κB Activation as a Pathological Mechanism of Septic Shock and Inflammation. American Journal of Physiology-Lung Cellular and Molecular Physiology, 290, L622-L645. [Google Scholar] [CrossRef] [PubMed]
[21] Lawrence, T. (2009) The Nuclear Factor NF-B Pathway in Inflammation. Cold Spring Harbor Perspectives in Biology, 1, a001651. [Google Scholar] [CrossRef] [PubMed]
[22] Raia, L. and Zafrani, L. (2022) Endothelial Activation and Microcirculatory Disorders in Sepsis. Frontiers in Medicine, 9, Article ID: 907992. [Google Scholar] [CrossRef] [PubMed]
[23] Kellum, J.A., Wen, X., de Caestecker, M.P. and Hukriede, N.A. (2019) Sepsis-Associated Acute Kidney Injury: A Problem Deserving of New Solutions. Nephron, 143, 174-178. [Google Scholar] [CrossRef] [PubMed]
[24] Zarbock, A., Gomez, H. and Kellum, J.A. (2014) Sepsis-Induced Acute Kidney Injury Revisited: Pathophysiology, Prevention and Future Therapies. Current Opinion in Critical Care, 20, 588-595. [Google Scholar] [CrossRef] [PubMed]
[25] Feng, J., Liu, K., Abraham, E., Chen, C., Tsai, P., Chen, Y., et al. (2014) Serum Estradiol Levels Predict Survival and Acute Kidney Injury in Patients with Septic Shock—A Prospective Study. PLOS ONE, 9, e97967. [Google Scholar] [CrossRef] [PubMed]
[26] Peerapornratana, S., Manrique-Caballero, C.L., Gómez, H. and Kellum, J.A. (2019) Acute Kidney Injury from Sepsis: Current Concepts, Epidemiology, Pathophysiology, Prevention and Treatment. Kidney International, 96, 1083-1099. [Google Scholar] [CrossRef] [PubMed]
[27] Tonnus, W., Meyer, C., Steinhoff, A., et al. (2025) Hydroxyestradiol Suppresses Ferroptosis to Protect the Kidney from Ischemic Injury. Nature, 634, 623-630.
[28] Ren, L., Li, F., Di, Z., Xiong, Y., Zhang, S., Ma, Q., et al. (2022) Estradiol Ameliorates Acute Kidney Ischemia-Reperfusion Injury by Inhibiting the TGF-βRI-SMAD Pathway. Frontiers in Immunology, 13, Article ID: 822604. [Google Scholar] [CrossRef] [PubMed]
[29] Hollenberg, S.M. and Singer, M. (2021) Pathophysiology of Sepsis-Induced Cardiomyopathy. Nature Reviews Cardiology, 18, 424-434. [Google Scholar] [CrossRef] [PubMed]
[30] Xerri, A., Gallardo, F., Kober, F., Mathieu, C., Fourny, N., Tran, T.T., et al. (2022) Female Hormones Prevent Sepsis-Induced Cardiac Dysfunction: An Experimental Randomized Study. Scientific Reports, 12, Article No. 4939. [Google Scholar] [CrossRef] [PubMed]
[31] Hsieh, Y., Choudhry, M.A., Huang-Ping, Y., Shimizu, T., Yang, S., Suzuki, T., et al. (2006) Inhibition of Cardiac Pgc‐1α Expression Abolishes Erβ Agonist‐Mediated Cardioprotection Following Trauma‐Hemorrhage. The FASEB Journal, 20, 1109-1117. [Google Scholar] [CrossRef] [PubMed]
[32] Lagranha, C.J., Deschamps, A., Bhatt, N.Y., et al. (2010) Estrogen Modulates Mitochondrial Cardioprotection via PI3K-Dependent Mechanisms. Journal of Molecular and Cellular Cardiology, 49, 1021-1028.
[33] Xiang, D., Liu, Y., Zhou, S., Zhou, E. and Wang, Y. (2021) Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 5523516. [Google Scholar] [CrossRef] [PubMed]
[34] Hamilton, K.L., Mbai, F.N., Gupta, S. and Knowlton, A.A. (2004) Estrogen, Heat Shock Proteins, and NFκB in Human Vascular Endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1628-1633. [Google Scholar] [CrossRef] [PubMed]
[35] Nesseler, N., Launey, Y., Aninat, C., Morel, F., Mallédant, Y. and Seguin, P. (2012) Clinical Review: The Liver in Sepsis. Critical Care, 16, Article 235. [Google Scholar] [CrossRef] [PubMed]
[36] Şener, G., Arbak, S., Kurtaran, P., Gedik, N. and Yeğen, B.Ç. (2005) Estrogen Protects the Liver and Intestines against Sepsis-Induced Injury in Rats. Journal of Surgical Research, 128, 70-78. [Google Scholar] [CrossRef] [PubMed]
[37] Eisa, M.A., Mansour, A.M., Salama, S.A., et al. (2021) Estrogen/Estrogen Receptor Activation Protects against DEN-Induced Liver Fibrosis in Female Rats via Modulating TLR-4/NF-κB Signaling. Toxicology and Applied Pharmacology, 431, Article 115740.
[38] Thompson, B.T., Chambers, R.C. and Liu, K.D. (2017) Acute Respiratory Distress Syndrome. New England Journal of Medicine, 377, 562-572. [Google Scholar] [CrossRef] [PubMed]
[39] Speyer, C.L., Rancilio, N.J., McClintock, S.D., Crawford, J.D., Gao, H., Sarma, J.V., et al. (2005) Regulatory Effects of Estrogen on Acute Lung Inflammation in Mice. American Journal of Physiology-Cell Physiology, 288, C881-C890. [Google Scholar] [CrossRef] [PubMed]
[40] Liao, W., Wu, S., Tsai, S., Pao, H., Huang, K. and Chu, S. (2021) 2-Methoxyestradiol Protects against Lung Ischemia/Reperfusion Injury by Upregulating Annexin A1 Protein Expression. Frontiers in Immunology, 12, Article ID: 596376. [Google Scholar] [CrossRef] [PubMed]
[41] Yeh, C., Chou, W., Chu, C., So, E.C., Chang, H., Wang, J., et al. (2011) Anticancer Agent 2-Methoxyestradiol Improves Survival in Septic Mice by Reducing the Production of Cytokines and Nitric Oxide. Shock, 36, 510-516. [Google Scholar] [CrossRef] [PubMed]
[42] Li, Z., Chen, H., Lv, J., et al. (2020) Estradiol and Brain Protection: Mechanisms and Clinical Implications. Brain Research Bulletin, 158, 156-168.
[43] Sharawy, N., Pavlovic, D., Wendt, M., Cerny, V. and Lehmann, C. (2011) Evaluation of the Effects of Gender and Estradiol Treatment on the Intestinal Microcirculation during Experimental Sepsis. Microvascular Research, 82, 397-403. [Google Scholar] [CrossRef] [PubMed]
[44] Darabi, M., Ani, M., Movahedian, A., et al. (2008) Effect of Estrogen on Platelet Aggregation and Activation in Whole Blood. Journal of Thrombosis and Thrombolysis, 26, 213-218.
[45] Kalaitzidis, D. and Gilmore, T.D. (2005) Transcription Factor Cross-Talk: The Estrogen Receptor and NF-κB. Trends in Endocrinology & Metabolism, 16, 46-52. [Google Scholar] [CrossRef] [PubMed]
[46] Ghisletti, S., Meda, C., Maggi, A. and Vegeto, E. (2005) 17β-Estradiol Inhibits Inflammatory Gene Expression by Controlling NF-κB Intracellular Localization. Molecular and Cellular Biology, 25, 2957-2968. [Google Scholar] [CrossRef] [PubMed]
[47] Xing, D., Oparil, S., Yu, H., Gong, K., Feng, W., Black, J., et al. (2012) Estrogen Modulates NF-κB Signaling by Enhancing IΚBα Levels and Blocking P65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-β. PLOS ONE, 7, e36890. [Google Scholar] [CrossRef] [PubMed]
[48] Zhang, M., Chen, H., Yang, Z., Zhang, M., Wang, X., Zhao, K., et al. (2021) 17β‐Estradiol Attenuates LPS‐Induced Macrophage Inflammation in Vitro and Sepsis‐Induced Vascular Inflammation in Vivo by Upregulating Mir‐29a‐5p Expression. Mediators of Inflammation, 2021, Article ID: 9921897. [Google Scholar] [CrossRef] [PubMed]
[49] Saeed, S., Quintin, J., Kerstens, H.H.D., Rao, N.A., Aghajanirefah, A., Matarese, F., et al. (2014) Epigenetic Programming of Monocyte-to-Macrophage Differentiation and Trained Innate Immunity. Science, 345, Article 1251086. [Google Scholar] [CrossRef] [PubMed]
[50] Dong, W., Chen, T., Miao, M., et al. (2017) Protective Effect of 17β-Estradiol on Acute Lung Injury Induced by Lipopolysaccharide in Rats. International Immunopharmacology, 52, 55-63.
[51] Morkuniene, R., Arandarcikaite, O. and Borutaite, V. (2006) Estradiol Prevents Release of Cytochrome C from Mitochondria and Inhibits Ischemia-Induced Apoptosis in Perfused Heart. Experimental Gerontology, 41, 704-708. [Google Scholar] [CrossRef] [PubMed]
[52] Mendelsohn, M.E. and Karas, R.H. (1999) The Protective Effects of Estrogen on the Cardiovascular System. New England Journal of Medicine, 340, 1801-1811. [Google Scholar] [CrossRef] [PubMed]
[53] Chambliss, K.L. and Shaul, P.W. (2002) Estrogen Modulation of Endothelial Nitric Oxide Synthase. Endocrine Reviews, 23, 665-686. [Google Scholar] [CrossRef] [PubMed]
[54] Simoncini, T. and Genazzani, A. (2003) Non-Genomic Actions of Sex Steroid Hormones. European Journal of Endocrinology, 148, 281-292. [Google Scholar] [CrossRef] [PubMed]
[55] Razandi, M., Pedram, A., Park, S.T. and Levin, E.R. (2003) Proximal Events in Signaling by Plasma Membrane Estrogen Receptors. Journal of Biological Chemistry, 278, 2701-2712. [Google Scholar] [CrossRef] [PubMed]
[56] Hsu, J.T., Kan, W.H., Hsieh, C.H., et al. (2008) Role of Estrogen Receptor in Trauma-Hemorrhage-Induced Activation of PI3K/Akt Pathway. Molecular Medicine Reports, 1, 347-351.
[57] Liu, H., Liu, K., Zhou, G.J., et al. (2011) 17beta-Estradiol Reduces Apoptosis and Attenuates ROS Production by Inhibiting p53 Phosphorylation and Translocation to Mitochondria in Cardiomyocytes after Hypoxia and Reoxygenation. American Journal of Physiology-Cell Physiology, 300, C23-C32.
[58] Yang, L., Bhattacharya, D. and Bhattacharya, S. (2020) Role of Autophagy in ER Stress and Mitophagy-Mediated Cardiovascular Protection. Autophagy, 16, 1333-1335.
[59] Spratt, D.I., Morton, J.R., Kramer, R.S., Mayo, S.W., Longcope, C. and Vary, C.P.H. (2006) Increases in Serum Estrogen Levels during Major Illness Are Caused by Increased Peripheral Aromatization. American Journal of Physiology-Endocrinology and Metabolism, 291, E631-E638. [Google Scholar] [CrossRef] [PubMed]
[60] May, A.K., Dossett, L.A., Norris, P.R., Hansen, E.N., Dorsett, R.C., Popovsky, K.A., et al. (2008) Estradiol Is Associated with Mortality in Critically Ill Trauma and Surgical Patients. Critical Care Medicine, 36, 62-68. [Google Scholar] [CrossRef] [PubMed]
[61] Kang, S., Matsutani, T., Choudhry, M.A., et al. (2004) Are the Immune Responses Different in Middle-Aged and Young Mice Following Bone Fracture, Tissue Trauma and Hemorrhage? Cytokine, 26, 223-230. [Google Scholar] [CrossRef] [PubMed]
[62] Hotchkiss, R.S., Monneret, G. and Payen, D. (2013) Sepsis-Induced Immunosuppression: From Cellular Dysfunctions to Immunotherapy. Nature Reviews Immunology, 13, 862-874. [Google Scholar] [CrossRef] [PubMed]
[63] Hsu, J.T., Kan, W.H., Hsieh, C.H., et al. (2009) Role of ERbeta in Salutary Effects of 17beta-Estradiol on Cardiac Function Following Trauma-Hemorrhage. American Journal of Physiology-Heart and Circulatory Physiology, 297, H1003-H1009.
[64] Iorga, A., Cunningham, C.M., Moazeni, S., Ruffenach, G., Umar, S. and Eghbali, M. (2017) The Protective Role of Estrogen and Estrogen Receptors in Cardiovascular Disease and the Controversial Use of Estrogen Therapy. Biology of Sex Differences, 8, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[65] Dejager, L., Pinheiro, I., Dejonckheere, E. and Libert, C. (2011) Cecal Ligation and Puncture: The Gold Standard Model for Polymicrobial Sepsis? Trends in Microbiology, 19, 198-208. [Google Scholar] [CrossRef] [PubMed]
[66] Br. Haloho, A. (2025) Unveiling New Horizons: Estrogen as a Breakthrough Therapy for Sepsis. Journal of Cellular and Molecular Anesthesia, 10, e159284. [Google Scholar] [CrossRef
[67] Paterni, I., Granchi, C., Katzenellenbogen, J.A. and Minutolo, F. (2014) Estrogen Receptors Alpha (Erα) and Beta (Erβ): Subtype-Selective Ligands and Clinical Potential. Steroids, 90, 13-29. [Google Scholar] [CrossRef] [PubMed]
[68] Rietjens, I.M.C.M., Louisse, J. and Beekmann, K. (2016) The Potential Health Effects of Dietary Phytoestrogens. British Journal of Pharmacology, 174, 1263-1280. [Google Scholar] [CrossRef] [PubMed]
[69] Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al. (2002) Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women’s Health Initiative Randomized Controlled Trial. JAMA: The Journal of the American Medical Association, 288, 321-333. [Google Scholar] [CrossRef] [PubMed]
[70] Weniger, M., D’Haese, J.G., Angele, M.K. and Chaudry, I.H. (2015) Potential Therapeutic Targets for Sepsis in Women. Expert Opinion on Therapeutic Targets, 19, 1531-1543. [Google Scholar] [CrossRef] [PubMed]